Wunder mushroom gummies are sold by Wunder, but the maker’s current October 13, 2026 page says it no longer makes or sells Amanita muscaria gummies and that its current products contain no Amanita or muscimol. Wunder instead describes gummies and tablets with botanicals such as blue lotus, kava, and kanna; retailer listings still use older Amanita wording, so the current package label is the detail that matters before you buy.
Does Wunder currently sell Amanita muscaria gummies?
It says its current gummies, tablets, and chocolate bars contain no Amanita and no muscimol.
That matters because some retailer collection pages still describe Wunder products as Amanita or “entheogenic” blends. A retailer description is not a substitute for the package in front of you. Before ordering, ask for a photo of the current ingredient panel and the matching batch report for the exact flavor and package size.
For the broader category, this amanita muscaria gummies guide explains the effects, safety questions, legality, and price differences readers may see across brands.
What does Wunder say is in its current gummies?
Wunder’s maker says its current options use botanicals including blue lotus, kava, and kanna, along with a proprietary blend. It identifies Blue Lotus + Pink Lemonade, Kava + Grape, Kanna + Pineapple, and Maxx Trippy Tablets as current alternatives to its former Amanita products.
| What to check | What the current Wunder page says | Why it matters |
|---|---|---|
| Amanita and muscimol | Neither is in current Wunder products. | This conflicts with older retailer descriptions using Amanita terminology. |
| Named botanicals | Blue lotus, kava, and kanna are named for current products. | Ingredients can differ by flavor and product type. |
| Label and batch report | Ask for documents tied to the exact item you intend to buy. | They help match the product and its ingredient panel. |
What do Amanita muscaria effects feel like?
The CDC’s 2024 report calls Amanita muscaria a hallucinogenic mushroom and says it can cause hallucinations, agitation, gastrointestinal upset, and seizures. In adults who consumed mushroom gummies, CDC also describes altered mental status, rapid heart rate, and gastrointestinal upset. In everyday terms, this is not simply a candy-like “mushroom high”: it can involve perception changes alongside confusion, agitation, nausea, or more serious reactions.
A 2025 case-report review in Acta Medica Lituanica described four hospital-treated intentional Amanita poisonings in Lithuania in 2023. The reported symptoms included tremors, dizziness, paranoia, nausea, and, in one case, respiratory failure requiring ventilation. These are reports of mushroom consumption, not a result study of current Wunder products.
Is Amanita muscaria legal, and why is it sold?
CDC wrote in its 2024 report that Amanita muscaria was currently legal, unlike psilocybin-containing mushrooms. That legal status is separate from food regulation: the FDA said in December 2024 that Amanita muscaria, its extracts, and muscimol, ibotenic acid, and muscarine are not authorized ingredients in conventional food and recommended that people avoid foods containing them.
For the federal and state distinction, see amanita muscaria legality. A product can be marketed in a changing category while still raising separate food-safety and local-law questions.
Could a mushroom gummy affect a drug test?
Amanita muscaria and psilocybin are different mushrooms and different compounds. In the CDC investigation, three of five tested brands marketed as Amanita or other mushroom nootropic gummies contained unlabeled psilocybin or psilocin, both Schedule I substances. The tested brands were not identified as Wunder products.
That finding means a product name alone cannot answer a workplace or legal testing question. Whether a particular item could affect a test depends on its actual contents and the test used. Readers comparing these categories can review amanita muscaria vs psilocybin mushrooms for the ingredient and effect differences.
How much do Wunder products cost?
Prices below were shown on Cannabis Pharmacy’s Wunder collection on October 24, 2026; check the checkout for today’s price and the exact product description.
| Retailer listing | Price shown | What the listing identifies |
|---|---|---|
| Grape Mushroom Gummies with Kava | $7.00 | Wunder grape gummies with kava |
| Pineapple Mushroom Gummies with Kanna | $30.00 | Wunder pineapple gummies with kanna |
| Mushroom Tablets Maxx | $10.00 | Wunder chewable tablets |
The same collection lists other Wunder flavors and package sizes without a displayed price in the captured listing. Confirm the flavor, ingredient panel, package count, shipping terms, and return terms before paying.
What about lion’s mane, feeling weird, or comparisons with Adderall?
Wunder’s current Amanita page names blue lotus, kava, and kanna, not lion’s mane. If a different mushroom gummy lists lion’s mane, Memorial Sloan Kettering Cancer Center says lion’s mane is used for general health and that reported adverse reactions in a clinical study included abdominal discomfort, nausea, and skin rash. Those symptoms give a concrete reason to stop treating a new reaction as a normal part of a gummy experience and seek timely medical help if symptoms are concerning.
A label that combines several botanicals makes the individual contributor to an effect harder to identify.
What should you confirm before buying any mushroom gummy?
- Read the current package’s full ingredient panel, rather than relying on an older retailer title.
- Ask for a batch-specific lab report that matches the flavor and package you intend to purchase.
- Check whether the product contains Amanita, muscimol, cannabinoids, kava, kanna, blue lotus, or other active ingredients.
- Confirm your state’s current rules for the exact product category.
- Check the seller’s current price, return terms, and contact route before checkout.
The FDA recommends avoiding foods containing Amanita muscaria or its constituents. If someone develops symptoms after consuming a mushroom gummy, CDC says to seek immediate medical attention.
By HealthDataConsortium.org Research Team
